幕上高血压性脑出血微创颅内血肿抽吸引流术1年预后相关因素分析

doi:10.3969/j.issn.1673-5765.2018.07.004

摘要/Abstract

摘要：

目的探讨幕上高血压性脑出血（intracerebral h emorrhage，ICH）微创颅内血肿抽吸引流术1年预后及其相关因素。

方法收集2014年1月-2016年8月就诊的进行微创颅内血肿抽吸引流术的幕上高血压性ICH患者。记录患者人口学特征等基本信息、临床信息、手术治疗信息及1年改良Rankin量表（modified Rankin scale， mRS）评分。主要临床结局为1年预后不良，定义为1年mRS>3分。用多因素Logistic回归分析1年预后不良的相关因素。

结果研究共纳入117例完成微创颅内血肿抽吸引流术的幕上高血压性I C H患者。平均年龄（56.5±12.5）岁，基线血肿体积（59.0±28.5）ml。59例（50.4%）ICH患者1年预后不良。多因素Logistic 回归分析显示，基线血肿体积20～50 ml[比值比（odds ratio，OR）0.161，95%置信区间（confidence interval，CI）0.034～0.748，P =0.020]、年龄≤60岁（OR 0.169，95%CI 0.055～0.515，P =0.002）是1年预后不良的保护性因素。

结论基线血肿体积和年龄是幕上高血压性ICH微创颅内血肿抽吸引流术1年预后的独立影响因素，该结论为选择微创颅内血肿抽吸引流术适宜人群提供依据。

文章导读： 多因素分析显示，基线血肿体积和年龄是幕上高血压性脑出血微创颅内血肿抽吸引流术1年预后的独立影响因素。

关键词: 脑出血; 微创颅内血肿抽吸引流术; 预后; 影响因素

Abstract:

Objective To study 1-year clinical outcomes after minimally invasive catheter evacuation followed by urokinase for clot removal in patients with acute supratentorial spontaneous intracerebral hemorrhage (ICH) and determine the factors associated with the 1-year outcome. Methods Supratentorial spontaneous ICH patients who had undergone minimally invasive catheter evacuation followed by urokinase for clot removal during January 2014 and September 2016 were collected . Patients' demographic and clinical information, surgery information and one-year modified Rankin scale (mRS) were recorded. The main clinical outcome was poor outcome, defined as mRS score >3 at 1 year. The multi-factor logistic regression analysis was used to determine factors associated with 1-year clinical outcome after ICH. Results A total of 117 patients with supratentorial spontaneous ICH and having undergone minimally invasive surgery were enrolled in the study. The mean age was (56.5±12.5) years and the mean baseline hematoma volume was (59.0±28.5) ml. 59 (50.4%) ICH patients had 1-year poor outcome after surgery. Multi-factor Logistic regression analysis revealed that baseline hematoma volume 20-50 ml [odds ratio (OR) 0.161, 95% confidence interval (CI) 0.034-0.748, P =0.020] and age≤60 years (OR 0.169, 95%CI 0.055-0.515, P =0.002) were independent protective factors of 1-year poor outcome. Conclusion Baseline hematoma volume and age were independent predictors of 1-year outcome in acute ICH patients who had undergone minimally invasive surgery, which could allow better selection of ICH patients appropriate for minimally invasive surgery.

Key words: Intracerebral hemorrhage; Minimally invasive surgery; Outcome; Influence factor

王文娟, 刘丽萍, 杨中华, 杨波, 李金鑫, 杜洋, 赵性泉. 幕上高血压性脑出血微创颅内血肿抽吸引流术1年预后相关因素分析[J]. 中国卒中杂志, 2018, 13(07): 656-661.

WANG Wen-Juan, LIU Li-Ping, YANG Zhong-Hua, YANG Bo, LI Jin-Xin, Du Yang, ZHAO Xing-Quan. Analysis of Related Factors of 1-year Outcome of Minimally Invasive Surgery in Supratentorial Spontaneous Intracerebral Hemorrhage[J]. Chinese Journal of Stroke, 2018, 13(07): 656-661.

参考文献

[1] FEIGIN V L，LAWES C M，BENNETT D A，et

al. Worldwide stroke incidence and early case

fatality reported in 56 population-based studies：A

systematic review[J]. Lancet Neurol，2009，8（4）：

355-369.

[2] VAN ASCH C J，LUITSE M J，RINKEL G J，et

al. Incidence，case fatality，and functional outcome

of intracerebral haemorrhage over time，according

to age，sex，and ethnic origin：A systematic review

and meta-analysis[J]. Lancet Neurol，2010，9（2）：

167-176.

[3] JIANG B，WANG W Z，CHEN H，et al. Incidence

and trends of stroke and its subtypes in China：

Results from three large cities[J]. Stroke，2006，37

（1）：63-68.

[4] ZHANG L F，YANG J，HONG Z，et al. Proportion

of different subtypes of stroke in China[J]. Stroke，

2003，34（9）：2091-2096.

[5] YANG Q D，NIU Q，ZHOU Y H，et al. Incidence of

cerebral hemorrhage in the Changsha community. A

prospective study from 1986 to 2000[J]. Cerebrovasc

Dis，2004，17（4）：303-313.

[6] WANG W J，LU J J，WANG Y J，et al. Clinical

characteristics，management，and functional

outcomes in Chinese patients within the first year

after intracerebral hemorrhage：Analysis from China

national stroke registry[J]. CNS Neurosci Ther，2012，

18（9）：773-780.

[7] HEMPHILL J C，BONOVICH D C，BESMERTIS

L，et al. The ICH score：A simple，reliable grading

scale for intracerebral hemorrhage[J]. Stroke，2001，

32（4）：891-897.

[8] HACHINSKI V，DONNAN G A，GORELICK P

B，et al. Stroke：Working toward a prioritized world

agenda[J]. Stroke，2010，41（6）：1084-1099. [9] CADILHAC D A，DEWEY H M，VOS T，et al. The

health loss from ischemic stroke and intracerebral

hemorrhage：evidence from the North East

Melbourne Stroke Incidence Study（NEMESIS）[J/

OL]. Health Qual Life Outcomes，2010，8：49. https：

//doi.org/10.1186/1477-7525-8-49.

[10] CHRISTENSEN M C，MAYER S，FERRAN J M.

Quality of life after intracerebral hemorrhage：results

of the Factor Seven for Acute Hemorrhagic stroke

（FAST）trial[J]. Stroke，2009，40（5）：1677-1682.

[11] MENDELOW A D，GREGSON B A，ROWAN E

N，et al. Early surgery versus initial conservative

treatment in patients with spontaneous supratentorial

lobar intracerebral haematomas（STICH II）：a

randomised trial[J]. Lancet，2013，382（9890）：397-

408.

[12] MENDELOW A D，GREGSON B A，ROWAN E

N，et al. Early Surgery versus Initial Conservative

Treatment in Patients with Traumatic Intracerebral

Hemorrhage（STITCH[Trauma]）：The First

Randomized Trial[J]. J Neurotrauma. 2015，32（17）：

1312-1323.

[13] HANLEY D F，THOMPSON R E，MUSCHELLI

J，et al. Safety and efficacy of minimally invasive

surgery plus alteplase in intracerebral haemorrhage

evacuation（MISTIE）：a randomised，controlled，

open-label，phase 2 trial[J]. Lancet Neurol，2016，15

（12）：1228-1237.

[14] Stroke--1989. Recommendations on stroke

prevention，diagnosis，and therapy. Report

of the WHO Task Force on Stroke and other

Cerebrovascular Disorders[J]. Stroke，1989，20（10）：

1407-1431.

[15] KOTHARI R U，BROTT T，BRODERICK J P，et al.

The ABCs of measuring intracerebral hemorrhage

volumes[J]. Stroke，1996，27（8）：1304-1305.

[16] WANG Y，CUI L，JI X，et al. The China

National Stroke Registry for patients with acute

cerebrovascular events：design，rationale，and

baseline patient characteristics[J]. Int J Stroke，2011，

6（4）：355-361.

[17] THABET A M，KOTTAPALLY M，HEMPHILL J C，

3rd. Management of intracerebral hemorrhage[J/OL].

Handb Clin Neurol，2017，140：177-194. https：//doi.

org/10.1016/B978-0-444-63600-3.00011-8.

[18] SUN H，LIU H，LI D，et al. An effective treatment

for cerebral hemorrhage：minimally invasive

craniopuncture combined with urokinase infusion

therapy[J]. Neurol Res，2010，32（4）：371-377.

[19] WANG W Z，JIANG B，LIU H M，et al. Minimally

invasive craniopuncture therapy vs. conservative

treatment for spontaneous intracerebral hemorrhage：

results from a randomized clinical trial in China[J].

Int J Stroke，2009，4（1）：11-16.

[20] BRODERICK J，CONNOLLY S，FELDMANN E，

et al. Guidelines for the management of spontaneous

intracerebral hemorrhage in adults：2007 update：a

guideline from the American Heart Association/

American Stroke Association Stroke Council，High

Blood Pressure Research Council，and the Quality

of Care and Outcomes in Research Interdisciplinary

Working Group[J]. Stroke. 2007，38（6）：2001-2023.

[21] AUER L M，DEINSBERGER W，NIEDERKORN

K，et al. Endoscopic surgery versus medical

treatment for spontaneous intracerebral hematoma：

a randomized study[J]. J Neurosurg，1989，70（4）：

530-535.

[22] ZHOU X，CHEN J，LI Q，et al. Minimally invasive

surgery for spontaneous supratentorial intracerebral

hemorrhage：a meta-analysis of randomized

controlled trials[J]. Stroke，2012，43（11）：2923-2930.

[23] KIM Y Z，KIM K H. Even in patients with a small

hemorrhagic volume，stereotactic-guided evacuation

of spontaneous intracerebral hemorrhage improves

functional outcome[J]. J Korean Neurosurg Soc，

2009，46：109-115.

[24] ZHOU H，ZHANG Y，LIU L，et al. Minimally

invasive stereotactic puncture and thrombolysis

therapy improves long-term outcome after acute

intracerebral hemorrhage[J]. J Neurol，2011，258（4）：

661-669.

[25] 王德江，王硕，赵元立，等. 高血压脑出血外科治疗

近期预后多因素分析[J]. 中华医学杂志，2005，85

（44）：3118-3122.

[26] 杨波，王晶，温淼，等. 微创颅内血肿抽吸引流术早

期预后影响因素分析[J]. 中国卒中杂志，2015，10

（11）：947-952.